Cargando…
Inferior immunogenicity and efficacy of respiratory syncytial virus fusion protein-based subunit vaccine candidates in aged versus young mice
Respiratory syncytial virus (RSV) is recognized as an important cause of lower and upper respiratory tract infections in older adults, and a successful vaccine would substantially lower morbidity and mortality in this age group. Recently, two vaccine candidates based on soluble purified glycoprotein...
Autores principales: | Cayatte, Corinne, Snell Bennett, Angie, Rajani, Gaurav Manohar, Hostetler, Leigh, Maynard, Sean K., Lazzaro, Michelle, McTamney, Patrick, Ren, Kuishu, O’Day, Terrence, McCarthy, Michael P., Schneider-Ohrum, Kirsten |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5705161/ https://www.ncbi.nlm.nih.gov/pubmed/29182682 http://dx.doi.org/10.1371/journal.pone.0188708 |
Ejemplares similares
-
Profile of patients with chemical injury and sensitivity.
por: Ziem, G, et al.
Publicado: (1997) -
A scalable and high yielding SARS-CoV-2 spike protein receptor binding domain production process
por: Riguero, Valeria, et al.
Publicado: (2023) -
DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials
por: Ledgerwood, Julie E, et al.
Publicado: (2011) -
Qualification of a Biolayer Interferometry Assay to Support AZD7442 Resistance Monitoring
por: Brady, Tyler, et al.
Publicado: (2022) -
The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
por: Spencer, Alexandra J, et al.
Publicado: (2022)